Trillium Therapeutics Inc

(NASDAQ:TRIL)

Latest On Trillium Therapeutics Inc (TRIL):

Date/Time Type Description Signal Details
2021-11-17 04:55 ESTNewsTrillium Therapeutics gains quickly after Nasdaq delisting notice on Pfizer dealN/A
2021-11-17 04:53 ESTNewsTrillium Therapeutics gets Canada, HSR approval for sale to PfizerN/A
2021-08-28 12:21 ESTNewsTrillium, Triple-S lead weekly healthcare gainers amid acquisitions; Cassava Sciences lagsN/A
2021-08-23 16:30 ESTNewsTrillium Therapeutics stock triples after acquisition by Pfizer for $2.3BN/A
2021-08-13 22:14 ESTNewsTrillium Therapeutics EPS misses by $0.04N/A
2021-08-09 16:11 ESTNewsTrillium gets dosing underway in early-stage acute myeloid leukemia studyN/A
2021-07-22 04:26 ESTNewsTrillium Therapeutics to join Russell 2000 and 3000 IndexN/A
2021-07-22 04:24 ESTNewsDosing underway in Trillium Therapeutics' mid-stage TTI-621 comb study in leiomyosarcomaN/A
2021-07-22 04:23 ESTNewsTrillium Therapeutics adds Catherine Mackey to its board of directorsN/A
2021-07-22 04:19 ESTNewsDosing underway in Trillium Therapeutics' Phase 1b/2 TTI-622 combo study in acute myeloid leukemiaN/A
2021-04-14 15:02 ESTNewsOrganigram cut on profitability concerns, Novocure downgraded despite positive news, and more in today's analyst actionN/A
2021-04-14 15:01 ESTNewsTrillium Therapeutics' CD47 Lead Evokes Pfizer's InterestN/A
2021-01-19 04:05 ESTNewsTrillium Therapeutics: A Potentially Undervalued CD47 PlayerN/A
2020-12-11 12:52 ESTNewsTrillium Therapeutics (TRIL) Presents At 62nd Virtual Annual Meeting of ASH - SlideshowN/A
2020-12-08 13:24 ESTNewsTrillium ticks lower on underwhelming data from TT1-622/621 in hematological malignancies trialsN/A
2020-11-26 21:48 ESTFinancialsCompany financials have been released.Neutral
2020-11-18 05:01 ESTFinancialsCompany financials have been released.Neutral
2020-11-17 21:34 ESTNewsTrillium Therapeutics reports 9M resultsN/A
2020-11-14 13:00 ESTNewsTrillium Therapeutics: Investors To See Further Upside Via CD47 FocusN/A
2020-11-08 01:07 ESTFinancialsCompany financials have been released.Neutral
2020-11-07 17:22 ESTFinancialsCompany financials have been released.Neutral
2020-10-12 17:13 ESTNewsTrillium started at Street-high $28 price target by new bull EvercoreN/A
2020-10-05 18:22 ESTNewsTrillium Therapeutics secures two new patents in U.S.N/A
2020-09-26 14:17 ESTFinancialsCompany financials have been released.Neutral
2020-09-17 06:28 ESTFinancialsCompany financials have been released.Neutral
2020-09-11 12:39 ESTNewsTrillium prices equity offering at $13N/A
2020-09-10 07:09 ESTNewsTrillium launches 8.5M-share stock offeringN/A
2020-09-09 01:44 ESTNewsEncouraging data on blood cancer candidates lifts Trillium, up 40%N/A
2020-08-14 10:22 ESTFinancialsCompany financials have been released.Neutral
2020-08-14 01:53 ESTFinancialsCompany financials have been released.Neutral
2020-08-13 02:13 ESTNewsTrillium Therapeutics reports 1H resultsN/A
2020-08-06 14:08 ESTFinancialsCompany financials have been released.Neutral
2020-08-06 09:44 ESTFinancialsCompany financials have been released.Neutral
2020-07-30 18:07 ESTFinancialsCompany financials have been released.Neutral
2020-07-30 06:04 ESTFinancialsCompany financials have been released.Neutral
2020-07-29 22:11 ESTFinancialsCompany financials have been released.Neutral
2020-07-27 13:59 ESTFinancialsCompany financials have been released.Neutral
2020-07-23 18:42 ESTFinancialsCompany financials have been released.Neutral
2020-07-09 10:12 ESTFinancialsCompany financials have been released.Neutral
2020-07-01 17:58 ESTFinancialsCompany financials have been released.Neutral
2020-06-19 13:51 ESTFinancialsCompany financials have been released.Neutral
2020-06-14 05:55 ESTFinancialsCompany financials have been released.Neutral
2020-06-12 06:41 ESTFinancialsCompany financials have been released.Neutral
2020-05-29 21:09 ESTNewsTrillium Therapeutics (TRIL) Investor Presentation - SlideshowN/A
2020-05-27 06:29 ESTFinancialsCompany financials have been released.Neutral
2020-05-21 02:03 ESTFinancialsCompany financials have been released.Neutral
2020-05-20 17:43 ESTFinancialsCompany financials have been released.Neutral
2020-05-18 05:21 ESTNewsTrillium Therapeutics EPS misses by $0.97N/A
2020-05-06 06:38 ESTFinancialsCompany financials have been released.Neutral
2020-05-01 06:00 ESTFinancialsCompany financials have been released.Neutral

About Trillium Therapeutics Inc (TRIL):

Trillium Therapeutics Inc., a clinical stage immuno-oncology company, develops therapies for the treatment of cancer. The company's lead program is TTI-621, a SIRPaFc fusion protein that acts a soluble decoy receptor preventing CD47 from delivering its inhibitory signal, which is in Phase I clinical trial for advanced relapsed or refractory hematologic malignancies, and solid tumors and mycosis fungoides. Its product candidates also include TTI-622 that is in Phase I clinical trial of immunoglobulin G4 SIRPaFc protein; and TTI-10001, a small molecule stimulator of interferon genes agonist that senses cytosolic DNA for promoting tumor immunity, which is in the discovery Phase. The company was formerly known as Stem Cell Therapeutics Corp. and changed its name to Trillium Therapeutics Inc. in June 2014. Trillium Therapeutics Inc. was founded in 2004 is headquartered in Mississauga, Canada.

TRIL Quotes by TradingView

See Advanced Chart

General

  • Name Trillium Therapeutics Inc
  • Symbol TRIL
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryBiotechnology
  • Last Split Factor1:30
  • Last Split Date2014-11-20
  • Fiscal Year EndDecember
  • IPO Date2005-03-23
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryBiotechnology
  • Gic SubIndustryBiotechnology
  • Web URLhttp://trilliumtherapeutics.com
View More

Valuation

  • Price/Sales (Trailing 12 Mt.) 6772.95
  • Price/Book (Most Recent Quarter) 7.17
  • Enterprise Value Revenue 7847.49
View More

Financials

  • Most Recent Quarter 2020-09-30
  • Operating Margin -43411%
  • Return on Assets -19%
  • Return on Equity -189%
  • Revenue 115000
  • Earnings Per Share -$2.55
  • Revenue Per Share $0
  • Gross Profit 124000
  • Quarterly Earnings Growth 360%
View More

Highlights

  • Market Capitalization 1.09 billion
  • Analyst Target Price $11.02
  • Book Value Per Share $1.64
View More

Share Statistics

  • Shares Outstanding 100.71 million
  • Shares Float 83.86 million
  • % Held by Insiders <1%
  • % Held by Institutions 68.87%
  • Shares Short 8.22 million
  • Shares Short Prior Month 8.9 million
  • Short Ratio 5.52
  • Short % of Float 8%
  • Short % of Shares Outstanding 8%
View More

Technicals

  • Beta 1.96
  • 52 Week High $20.96
  • 52 Week Low $3.01
  • 50 Day Moving Average 12.12
  • 200 Day Moving Average 13.6
View More

Dividends

  • Dividend Date N/A
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

Trillium Therapeutics Inc (TRIL) Dividend Calendar:

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Trillium Therapeutics Inc (TRIL) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-09-302020-11-16$N/A-$0.55-$0.17-226.33%
2020-06-302020-08-12$N/A-$0.57-$0.12-392.51%
2020-03-312020-05-15$N/A-$1.07-$0.10-933.24%
2019-12-312020-03-10$-3213-$0.42-$0.22-92.94%
2019-09-302019-11-14$98935.13-$0.35-$0.33-4.77%
2019-06-302019-08-13$25981.97-$0.12-$0.4069.84%
2019-03-312019-05-13$N/A-$0.45-$0.40-12.19%
2018-12-312019-03-11$N/A-$0.43-$0.6535.03%
2018-09-302018-11-14$N/A-$0.69-$0.68-1.49%
2018-06-302018-08-08$N/A-$0.71-$0.65-9.29%
2018-03-312018-05-11$N/A-$0.51-$0.6420.61%
2017-12-312018-03-09$N/A-$0.66-$0.7310.12%
2017-09-302017-11-10$N/A-$0.77-$0.858.88%
2017-06-302017-08-11$N/A-$1.05-$1.083.27%
2017-03-312017-05-12$N/A-$1.06-$0.92-15.64%
2016-12-312017-03-10$N/A-$0.85-$0.927.63%
2016-09-302016-11-10$N/A-$0.75-$0.773.02%
2016-06-302016-08-12$N/A-$0.75-$0.74-1.52%
2016-03-312016-05-13$N/A-$0.71-$0.67-5.65%
2015-12-312016-03-09$N/A-$0.29-$0.8264.98%
2015-09-302015-11-10$N/A-$0.21-$1.0580%
2015-06-302015-08-11$N/A-$0.80-$0.75-6.67%
2015-03-312015-04-01$N/A-$0.98-$0.60-63.33%
2014-12-312015-03-22$N/A-$0.97-$0.68-42.65%
2014-09-302014-11-13$N/A-$0.55
2014-06-302014-08-12$N/A-$0.89
2014-03-312014-05-20$N/A-$0.45
2013-09-302013-11-01$N/A-$0.88
2013-06-302013-08-28$N/A-$0.98
2013-03-312013-05-24$N/A-$0.48
2012-12-312012-12-31$N/A-$0.02
2012-09-302012-09-30$N/A-$0.65
2012-06-302012-06-30$N/A-$0.50
2012-03-312012-03-31$N/A-$0.53
2011-12-312011-12-31-$2.34
2011-09-302011-09-30-$1.05
2011-06-302011-06-30-$1.16
2011-03-312011-03-31-$0.79
2010-12-312010-12-31-$1.64
2010-09-302010-09-30-$2.89
2010-06-302010-06-30-$2.92
2010-03-312010-03-31-$2.44
2009-12-312009-12-31-$2.84
2009-09-302009-09-30-$3.07
2009-06-302009-06-30-$1.91
2009-03-312009-03-31-$1.60
2008-12-312008-12-31-$2.76
2008-09-302008-09-30-$3.99
2008-06-302008-06-30-$4.41
2008-03-312008-03-31-$3.91
2007-12-312007-12-31-$6.12
2007-09-302007-09-30-$5.57
2007-06-302007-06-30-$3.24
2007-03-312007-03-31-$5.28

Trillium Therapeutics Inc (TRIL) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

Trillium Therapeutics Inc (TRIL) Chart:

Trillium Therapeutics Inc (TRIL) News:

Below you will find a list of latest news for Trillium Therapeutics Inc (TRIL) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Trillium Therapeutics Inc (TRIL) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent

Trillium Therapeutics Inc (TRIL) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-05-296-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1616212/000106299320002648/0001062993-20-002648-index.htm
2018-05-24UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1616212/000000000018016193/0000000000-18-016193-index.htm
2020-05-06UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1616212/000000000020003968/0000000000-20-003968-index.htm
2018-02-06SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1616212/000081229518000021/0000812295-18-000021-index.htm
2018-12-21SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1616212/000089542118000638/0000895421-18-000638-index.htm
2019-02-12SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1616212/000089542119000072/0000895421-19-000072-index.htm
2019-12-31SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1616212/000089542119000687/0000895421-19-000687-index.htm
2020-02-13SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1616212/000089542120000174/0000895421-20-000174-index.htm
2020-05-11SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1616212/000089542120000350/0000895421-20-000350-index.htm
2017-12-08SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1616212/000090266417004518/0000902664-17-004518-index.htm
2019-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1616212/000090266419001098/0000902664-19-001098-index.htm
2019-03-04SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1616212/000090266419001363/0000902664-19-001363-index.htm
2020-01-21SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1616212/000090266420000305/0000902664-20-000305-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1616212/000090266420001126/0000902664-20-001126-index.htm
2019-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1616212/000092963819000264/0000929638-19-000264-index.htm
2017-11-136-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1616212/000106299317004778/0001062993-17-004778-index.htm
2017-11-136-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1616212/000106299317004785/0001062993-17-004785-index.htm
2017-11-156-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1616212/000106299317004978/0001062993-17-004978-index.htm
2017-11-156-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1616212/000106299317005004/0001062993-17-005004-index.htm
2017-11-206-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1616212/000106299317005038/0001062993-17-005038-index.htm
2017-12-046-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1616212/000106299317005136/0001062993-17-005136-index.htm
2017-12-116-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1616212/000106299317005224/0001062993-17-005224-index.htm
2017-12-12DNotice of Exempt Offering of Securitieshttps://www.sec.gov/Archives/edgar/data/1616212/000106299317005233/0001062993-17-005233-index.htm
2017-12-15F-10Registration Statement for Securities of certain Canadian Issuers.https://www.sec.gov/Archives/edgar/data/1616212/000106299317005267/0001062993-17-005267-index.htm
2017-12-15F-XAppointment of Agent for Service of Process and Undertakinghttps://www.sec.gov/Archives/edgar/data/1616212/000106299317005269/0001062993-17-005269-index.htm
2018-01-08F-10/ARegistration Statement for Securities of certain Canadian Issuers.https://www.sec.gov/Archives/edgar/data/1616212/000106299318000048/0001062993-18-000048-index.htm
2018-01-08F-10/ARegistration Statement for Securities of certain Canadian Issuers.https://www.sec.gov/Archives/edgar/data/1616212/000106299318000073/0001062993-18-000073-index.htm
2018-01-176-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1616212/000106299318000190/0001062993-18-000190-index.htm
2018-02-096-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1616212/000106299318000516/0001062993-18-000516-index.htm
2018-03-0940-FRegistration statement [Section 12] or Annual Report [Section 13(a), 15(d)]https://www.sec.gov/Archives/edgar/data/1616212/000106299318001130/0001062993-18-001130-index.htm
2018-03-096-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1616212/000106299318001131/0001062993-18-001131-index.htm
2018-03-1340-F/ARegistration statement [Section 12] or Annual Report [Section 13(a), 15(d)]https://www.sec.gov/Archives/edgar/data/1616212/000106299318001177/0001062993-18-001177-index.htm
2018-03-206-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1616212/000106299318001269/0001062993-18-001269-index.htm
2018-04-0440-F/ARegistration statement [Section 12] or Annual Report [Section 13(a), 15(d)]https://www.sec.gov/Archives/edgar/data/1616212/000106299318001503/0001062993-18-001503-index.htm
2018-04-106-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1616212/000106299318001561/0001062993-18-001561-index.htm
2018-04-126-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1616212/000106299318001603/0001062993-18-001603-index.htm
2018-04-186-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1616212/000106299318001710/0001062993-18-001710-index.htm
2018-05-116-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1616212/000106299318002096/0001062993-18-002096-index.htm
2018-05-16F-3Registration statement by foreign private issuershttps://www.sec.gov/Archives/edgar/data/1616212/000106299318002283/0001062993-18-002283-index.htm
2018-05-29CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1616212/000106299318002413/0001062993-18-002413-index.htm
2018-06-056-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1616212/000106299318002483/0001062993-18-002483-index.htm
2018-06-076-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1616212/000106299318002504/0001062993-18-002504-index.htm
2018-06-146-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1616212/000106299318002605/0001062993-18-002605-index.htm
2018-06-156-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1616212/000106299318002617/0001062993-18-002617-index.htm
2018-06-186-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1616212/000106299318002629/0001062993-18-002629-index.htm
2018-06-20SUPPLVoluntary Supplemental Material by Foreign Issuers [Section 11(a)]https://www.sec.gov/Archives/edgar/data/1616212/000106299318002666/0001062993-18-002666-index.htm
2018-06-206-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1616212/000106299318002667/0001062993-18-002667-index.htm
2018-06-206-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1616212/000106299318002668/0001062993-18-002668-index.htm
2018-06-256-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1616212/000106299318002711/0001062993-18-002711-index.htm
2018-08-086-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1616212/000106299318003174/0001062993-18-003174-index.htm
2018-08-306-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1616212/000106299318003586/0001062993-18-003586-index.htm
2018-09-126-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1616212/000106299318003714/0001062993-18-003714-index.htm
2018-09-276-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1616212/000106299318003860/0001062993-18-003860-index.htm
2018-09-286-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1616212/000106299318003874/0001062993-18-003874-index.htm
2018-11-146-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1616212/000106299318004585/0001062993-18-004585-index.htm
2018-12-036-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1616212/000106299318004870/0001062993-18-004870-index.htm
2019-02-216-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1616212/000106299319001035/0001062993-19-001035-index.htm
2019-02-22SUPPLVoluntary Supplemental Material by Foreign Issuers [Section 11(a)]https://www.sec.gov/Archives/edgar/data/1616212/000106299319001039/0001062993-19-001039-index.htm
2019-02-226-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1616212/000106299319001041/0001062993-19-001041-index.htm
2019-02-25SUPPLVoluntary Supplemental Material by Foreign Issuers [Section 11(a)]https://www.sec.gov/Archives/edgar/data/1616212/000106299319001062/0001062993-19-001062-index.htm
2019-02-256-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1616212/000106299319001064/0001062993-19-001064-index.htm
2019-03-086-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1616212/000106299319001215/0001062993-19-001215-index.htm
2019-03-1120-FAnnual and transition report of foreign private issuers [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1616212/000106299319001231/0001062993-19-001231-index.htm
2019-03-116-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1616212/000106299319001234/0001062993-19-001234-index.htm
2019-03-276-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1616212/000106299319001424/0001062993-19-001424-index.htm
2019-04-026-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1616212/000106299319001508/0001062993-19-001508-index.htm
2019-04-086-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1616212/000106299319001598/0001062993-19-001598-index.htm
2019-04-116-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1616212/000106299319001650/0001062993-19-001650-index.htm
2019-04-156-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1616212/000106299319001695/0001062993-19-001695-index.htm
2019-04-306-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1616212/000106299319001916/0001062993-19-001916-index.htm
2019-05-136-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1616212/000106299319002133/0001062993-19-002133-index.htm
2019-05-216-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1616212/000106299319002356/0001062993-19-002356-index.htm
2019-07-026-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1616212/000106299319002766/0001062993-19-002766-index.htm
2019-07-246-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1616212/000106299319002999/0001062993-19-002999-index.htm
2019-08-136-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1616212/000106299319003319/0001062993-19-003319-index.htm
2019-09-056-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1616212/000106299319003608/0001062993-19-003608-index.htm
2019-09-256-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1616212/000106299319003735/0001062993-19-003735-index.htm
2019-10-086-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1616212/000106299319003841/0001062993-19-003841-index.htm
2019-10-226-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1616212/000106299319003977/0001062993-19-003977-index.htm
2019-11-066-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1616212/000106299319004170/0001062993-19-004170-index.htm
2019-11-14S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1616212/000106299319004391/0001062993-19-004391-index.htm
2019-11-146-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1616212/000106299319004393/0001062993-19-004393-index.htm
2020-01-076-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1616212/000106299320000039/0001062993-20-000039-index.htm
2020-01-166-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1616212/000106299320000186/0001062993-20-000186-index.htm
2020-01-226-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1616212/000106299320000269/0001062993-20-000269-index.htm
2020-01-23SUPPLVoluntary Supplemental Material by Foreign Issuers [Section 11(a)]https://www.sec.gov/Archives/edgar/data/1616212/000106299320000272/0001062993-20-000272-index.htm
2020-01-236-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1616212/000106299320000274/0001062993-20-000274-index.htm
2020-01-236-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1616212/000106299320000281/0001062993-20-000281-index.htm
2020-01-23SUPPLVoluntary Supplemental Material by Foreign Issuers [Section 11(a)]https://www.sec.gov/Archives/edgar/data/1616212/000106299320000283/0001062993-20-000283-index.htm
2020-01-296-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1616212/000106299320000363/0001062993-20-000363-index.htm
2020-02-076-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1616212/000106299320000498/0001062993-20-000498-index.htm
2020-02-286-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1616212/000106299320001200/0001062993-20-001200-index.htm
2020-03-1040-FRegistration statement [Section 12] or Annual Report [Section 13(a), 15(d)]https://www.sec.gov/Archives/edgar/data/1616212/000106299320001304/0001062993-20-001304-index.htm
2020-03-106-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1616212/000106299320001306/0001062993-20-001306-index.htm
2020-04-086-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1616212/000106299320001697/0001062993-20-001697-index.htm
2020-04-236-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1616212/000106299320001910/0001062993-20-001910-index.htm
2020-04-23F-3Registration statement by foreign private issuershttps://www.sec.gov/Archives/edgar/data/1616212/000106299320001914/0001062993-20-001914-index.htm
2020-04-30F-3/ARegistration statement by foreign private issuershttps://www.sec.gov/Archives/edgar/data/1616212/000106299320002043/0001062993-20-002043-index.htm
2020-04-30CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1616212/000106299320002047/0001062993-20-002047-index.htm
2020-05-05424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1616212/000106299320002136/0001062993-20-002136-index.htm
2020-05-056-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1616212/000106299320002138/0001062993-20-002138-index.htm
2020-05-066-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1616212/000106299320002140/0001062993-20-002140-index.htm
2020-05-136-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1616212/000106299320002296/0001062993-20-002296-index.htm
2020-05-156-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1616212/000106299320002485/0001062993-20-002485-index.htm
2020-05-266-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1616212/000106299320002587/0001062993-20-002587-index.htm
2020-05-296-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1616212/000106299320002648/0001062993-20-002648-index.htm
2020-07-066-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1616212/000106299320003139/0001062993-20-003139-index.htm
2020-07-306-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1616212/000106299320003562/0001062993-20-003562-index.htm
2020-08-126-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1616212/000106299320003831/0001062993-20-003831-index.htm
2020-09-086-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1616212/000106299320004386/0001062993-20-004386-index.htm
2020-09-096-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1616212/000106299320004396/0001062993-20-004396-index.htm
2020-09-09424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1616212/000106299320004398/0001062993-20-004398-index.htm
2020-09-096-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1616212/000106299320004410/0001062993-20-004410-index.htm
2020-09-09424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1616212/000106299320004414/0001062993-20-004414-index.htm
2020-09-116-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1616212/000106299320004454/0001062993-20-004454-index.htm
2020-09-11424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1616212/000106299320004468/0001062993-20-004468-index.htm
2020-09-166-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1616212/000106299320004525/0001062993-20-004525-index.htm
2020-09-186-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1616212/000106299320004560/0001062993-20-004560-index.htm
2020-10-056-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1616212/000106299320004787/0001062993-20-004787-index.htm
2020-11-026-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1616212/000106299320005329/0001062993-20-005329-index.htm
2017-12-05SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1616212/000107261317000621/0001072613-17-000621-index.htm
2019-03-04SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1616212/000107261319000117/0001072613-19-000117-index.htm
2020-02-04SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1616212/000107261320000019/0001072613-20-000019-index.htm
2020-01-21SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1616212/000110465920005549/0001104659-20-005549-index.htm
2018-02-13SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1616212/000114420418007958/0001144204-18-007958-index.htm
2020-02-03SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1616212/000119312520022982/0001193125-20-022982-index.htm
2020-02-03SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1616212/000121390020002392/0001213900-20-002392-index.htm
2020-02-14SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1616212/000121465920001477/0001214659-20-001477-index.htm
2018-02-13SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1616212/000153526418000034/0001535264-18-000034-index.htm
2019-01-10SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1616212/000153526419000004/0001535264-19-000004-index.htm
2018-01-08EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1616212/999999999518000073/9999999995-18-000073-index.htm
2018-05-31EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1616212/999999999518001393/9999999995-18-001393-index.htm
2020-05-04EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1616212/999999999520001027/9999999995-20-001027-index.htm